Low Rates of Immunity among Medical Students and Residents in the Era of the Resurgence of Measles.

healthcare workers immunity measles measles outbreaks medical students vaccine

Journal

Pathogens (Basel, Switzerland)
ISSN: 2076-0817
Titre abrégé: Pathogens
Pays: Switzerland
ID NLM: 101596317

Informations de publication

Date de publication:
11 Sep 2024
Historique:
received: 01 08 2024
revised: 04 09 2024
accepted: 10 09 2024
medline: 28 9 2024
pubmed: 28 9 2024
entrez: 28 9 2024
Statut: epublish

Résumé

Measles is a highly contagious viral disease spread through respiratory droplets. The number of reported cases increased worldwide in 2023, particularly in the European Region. Italy reported 213 cases in the first quarter of 2024, with most of them in unvaccinated adults aged 15-64. Maintaining high vaccination coverage is essential to prevent outbreaks, especially in healthcare settings where measles transmission is a significant risk. In our study, we collected serological and demographic information from all Italian and foreign medical students and residents (850) who underwent a pre-training assessment at the Tor Vergata Occupational Medicine Service, Rome, between 3 April 2023 and 31 January 2024. Of the 850 students and residents analyzed, we found only 546 (64.2%) with a protective level of IgG antibodies against measles, with a median IgG level of 2.00 AI. A significant proportion of students and residents were serologically non-immune, raising concerns about the potential risk of hospital transmission. To manage this risk, it is important to assess serological levels, vaccinate those with inadequate levels, and promote vaccination in the general population.

Identifiants

pubmed: 39338975
pii: pathogens13090784
doi: 10.3390/pathogens13090784
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Cristiana Ferrari (C)

PhD Program in Social, Occupational and Medico-Legal Sciences, Department of Occupational, Medicine, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.
Department of Biomedicine and Prevention, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.

Giuseppina Somma (G)

Department of Biomedicine and Prevention, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.

Vittorio Caputi (V)

Department of Biomedicine and Prevention, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.

Michele Treglia (M)

Department of Biomedicine and Prevention, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.

Margherita Pallocci (M)

Department of Biomedicine and Prevention, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.

Fabian Cenko (F)

Faculty of Medicine, Catholic University of "Our Lady of Good Counsel", 1000 Tirana, Albania.

Ersilia Buonomo (E)

Faculty of Medicine, Catholic University of "Our Lady of Good Counsel", 1000 Tirana, Albania.

Mariachiara Carestia (M)

Faculty of Medicine, Catholic University of "Our Lady of Good Counsel", 1000 Tirana, Albania.

Luca Di Giampaolo (L)

Department of Occupational Medicine, University of Chieti "G. D'Annunzio", 66100 Chieti, Italy.

Ole F Olesen (OF)

European Vaccine Initiative, Universitätsklinikum Heidelberg (Heidelberg University Hospital), Voßstraße 2, 69115 Heidelberg, Germany.

Luca Coppeta (L)

Department of Biomedicine and Prevention, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.
Faculty of Medicine, Catholic University of "Our Lady of Good Counsel", 1000 Tirana, Albania.

Classifications MeSH